BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37102261)

  • 1. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
    Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
    Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
    Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
    Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.
    Huang L; Jin W; Bao Y; Zeng X; Zhang Y; Zhou J; Peng H
    Mutat Res; 2023; 827():111828. PubMed ID: 37437507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Signatures of Metabolic Genes and Metabolism-Related Long Non-coding RNAs Accurately Predict Overall Survival for Osteosarcoma Patients.
    Chao-Yang G; Rong T; Yong-Qiang S; Tai-Cong L; Kai-Sheng Z; Wei N; Hai-Hong Z
    Front Cell Dev Biol; 2021; 9():644220. PubMed ID: 33708772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma.
    Shao J; Zhang Y; Chang Z; Du S; Li W; Bai Y; Lu C; Xu T
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1758-1769. PubMed ID: 37814812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis.
    Teng JS; Wang Y
    Sci Rep; 2024 Jun; 14(1):13401. PubMed ID: 38862526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
    Zhang J; Liu J; Ding R; Miao X; Deng J; Zhao X; Wu T; Cheng X
    Aging (Albany NY); 2024 Mar; 16(6):5249-5263. PubMed ID: 38460960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
    Li T; Tang Z; Li S; Lu M
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an oxidative phosphorylation-related gene signature for predicting prognosis and identifying immune infiltration in osteosarcoma.
    Zhou P; Zhang J; Feng J; Wang G
    Aging (Albany NY); 2024 Mar; 16(6):5311-5335. PubMed ID: 38506898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of a novel NAD
    Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
    J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy.
    Wu Z; Yu J; Han T; Tu Y; Su F; Li S; Huang Y
    BMC Musculoskelet Disord; 2024 Jun; 25(1):437. PubMed ID: 38835052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma.
    Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J
    Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying four DNA methylation gene sites signature for predicting prognosis of osteosarcoma.
    Zhang X; Zheng Y; Li G; Yu C; Ji T; Miao S
    Transl Cancer Res; 2020 Nov; 9(11):7299-7309. PubMed ID: 35117331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
    Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
    Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
    Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
    Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel predictive biomarkers for osteosarcoma and glycolysis pathways: A profiling study on HS2ST1 and SDC3.
    Yang G; Jiang J; Yin R; Li Z; Li L; Gao F; Liu C; Zhan X
    Medicine (Baltimore); 2022 Sep; 101(36):e30192. PubMed ID: 36086752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.